<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Med (Praha)</journal-id><journal-id journal-id-type="iso-abbrev">Vet Med (Praha)</journal-id><journal-id journal-id-type="publisher-id">VETMED</journal-id><journal-title-group><journal-title>Veterin&#x000e1;rn&#x000ed; Medic&#x000ed;na</journal-title></journal-title-group><issn pub-type="ppub">0375-8427</issn><issn pub-type="epub">1805-9392</issn><publisher><publisher-name>Czech Academy of Agricultural Sciences</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12093463</article-id><article-id pub-id-type="publisher-id">124039</article-id><article-id pub-id-type="doi">10.17221/39/2024-VETMED</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Treatment tactic of&#x000a0;canine cranial cruciate ligament rupture management: A&#x000a0;28-day comparative analysis of&#x000a0;ACP and NSAID induced effects on&#x000a0;the serum MMP-3&#x000a0;levels and clinical outcomes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Raulinaite</surname><given-names>Kristina</given-names></name><xref rid="A1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Zelvyte</surname><given-names>Rasa</given-names></name><xref rid="A1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Skemiene</surname><given-names>Kristina</given-names></name><xref rid="A2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Monkeviciene</surname><given-names>Ingrida</given-names></name><xref rid="A1" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="A1"><sup>1</sup>Department of&#x000a0;Anatomy and Physiology, Faculty of&#x000a0;Veterinary, Veterinary Academy, Lithuanian University of&#x000a0;Health Sciences, Kaunas, Lithuania</aff><aff id="A2"><sup>2</sup>Laboratory of&#x000a0;Biochemistry, Neuroscience Institute, Lithuanian University of&#x000a0;Health Sciences, Kaunas, Lithuania</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author: <email xlink:href="kristina.raulinaite@lsmu.lt">kristina.raulinaite@lsmu.lt</email></corresp></author-notes><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>28</day><month>4</month><year>2025</year></pub-date><volume>70</volume><issue>4</issue><fpage>124</fpage><lpage>133</lpage><history><date date-type="received"><day>08</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>23</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2025 Raulinaite et al.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution-NonCommercial 4.0 International</ext-link> (CC BY-NC 4.0).</license-p></license></permissions><abstract><p>Cranial cruciate ligament rupture (CrCLR) is&#x000a0;a&#x000a0;common stifle joint pathology among dogs, leading to&#x000a0;osteoarthritis and painfulness. Non-surgical treatment options often represent the usage of&#x000a0;non-steroidal anti-inflammatory drugs for 14&#x000a0;days (NSAIDs), but autologous conditioned plasma (ACP) shows promising results in&#x000a0;managing various orthopaedic conditions, decreasing inflammation, and improving the clinical outcome in&#x000a0;dogs. This study aimed to&#x000a0;determine the differences in&#x000a0;MMP-3&#x000a0;serum levels and the clinical outcomes between differently treated cranial cruciate rupture cases. For this purpose, we&#x000a0;used two different treatment methods for managing canine cranial cruciate ligament rupture (minimally invasive ACP injection or&#x000a0;oral NSAIDs), and evaluated the&#x000a0;clinical outcomes, indicating the quality of&#x000a0;life, and the MMP-3&#x000a0;serum levels over a&#x000a0;period of&#x000a0;28&#x000a0;days. The&#x000a0;findings of&#x000a0;this investigation indicate that ACP has better efficacy than two weeks of&#x000a0;NSAIDs in&#x000a0;inflammation reduction, clinical outcome improvement, and the allowance of&#x000a0;a&#x000a0;longer duration of&#x000a0;activity after 28&#x000a0;days.</p></abstract><kwd-group><kwd>autologous conditioned plasma</kwd><kwd>dog</kwd><kwd>cranial cruciate ligament rupture</kwd><kwd>functional outcomes</kwd><kwd>matrix metalloproteinase 3</kwd><kwd>nonsteroidal anti-inflammatory drugs</kwd></kwd-group></article-meta></front><body><p>A&#x000a0;rupture of&#x000a0;the cranial cruciate ligament (CrCLR) is&#x000a0;a&#x000a0;frequent pathology affecting canine stifle joint (<xref rid="R23" ref-type="bibr">Johnson et&#x000a0;al. 1994</xref>; <xref rid="R12" ref-type="bibr">Comerford et&#x000a0;al. 2005</xref>; <xref rid="R10" ref-type="bibr">Clements et&#x000a0;al. 2008</xref>; <xref rid="R49" ref-type="bibr">Taylor-Brown et&#x000a0;al. 2015</xref>; <xref rid="R46" ref-type="bibr">Sellon and Marcellin-Little 2022</xref>). The pathology of&#x000a0;CrCLR can lead to&#x000a0;osteoarthritic changes of&#x000a0;various degrees in&#x000a0;the stifle (<xref rid="R54" ref-type="bibr">Vasseur and Berry 1992</xref>; <xref rid="R21" ref-type="bibr">Innes et&#x000a0;al. 2004</xref>; <xref rid="R4" ref-type="bibr">Bleedorn et&#x000a0;al. 2011</xref>; <xref rid="R1" ref-type="bibr">Alvarez et&#x000a0;al. 2022</xref>). The ruptured ligament also leads to&#x000a0;stifle instability, joint effusion, inflammation, and painfulness (<xref rid="R6" ref-type="bibr">Brandt et&#x000a0;al. 1991</xref>; <xref rid="R45" ref-type="bibr">Rayward et&#x000a0;al. 2004</xref>). The severity of&#x000a0;the osteoarthritis (OA) affects the CrCLR prognosis and the method of&#x000a0;its management (<xref rid="R9" ref-type="bibr">Chauvet et&#x000a0;al. 1996</xref>; <xref rid="R20" ref-type="bibr">Innes et&#x000a0;al. 2000</xref>).</p><p>The pathways affecting disturbance in the degradation and repair of the balance of cartilage matrix in OA are mediated through cytokines and chemokines (<xref rid="R14" ref-type="bibr">Fernandes et&#x000a0;al. 2002</xref>). The cytokine activities correlate with the functional alterations in&#x000a0;the synovial membrane, cartilage and subchondral bone, and are produced spontaneously or&#x000a0;subsequently stimulated by&#x000a0;cells in&#x000a0;the joint tissue (<xref rid="R34" ref-type="bibr">Martel-Pelletier et&#x000a0;al. 1999</xref>). Matrix metalloproteinease-3 (MMP-3) is&#x000a0;associated with OA and is&#x000a0;one of&#x000a0;the most sensitive matrix metalloproteineases (MMPs) in&#x000a0;cases of&#x000a0;canine CrCLR (<xref rid="R18" ref-type="bibr">Hegemann et&#x000a0;al. 2003</xref>; <xref rid="R17" ref-type="bibr">Hayashi et&#x000a0;al. 2004</xref>; <xref rid="R37" ref-type="bibr">Muir et&#x000a0;al. 2005</xref>). Biomarker MMP-3 is&#x000a0;locally produced and activated within the affected joint as&#x000a0;a&#x000a0;result of&#x000a0;the cytokine mediated stimulation. It&#x000a0;is&#x000a0;a&#x000a0;sensitive biomarker of&#x000a0;both canine and human OA (<xref rid="R41" ref-type="bibr">Qi&#x000a0;and Changlin 2007</xref>).</p><p>Biomarkers are useful in&#x000a0;evaluating OA, as&#x000a0;they can be&#x000a0;used to&#x000a0;assess the proteins or&#x000a0;enzymes directly or&#x000a0;indirectly affecting the joint inflammation and painfulness. The serum is&#x000a0;one of&#x000a0;the easiest biological fluids to&#x000a0;collect and is&#x000a0;a&#x000a0;suitable source of&#x000a0;biomarkers (<xref rid="R13" ref-type="bibr">De Gruttola et&#x000a0;al. 2001</xref>).</p><p>The non-surgical management of&#x000a0;CrCLR is&#x000a0;set to&#x000a0;maintain the patient&#x02019;s comfort levels and affected limb&#x02019;s functionality while non-steroidal anti-inflammatory drugs (NSAIDs) are a&#x000a0;part of&#x000a0;the most common non-surgical treatment options in&#x000a0;cases of&#x000a0;canine CrCLR (<xref rid="R25" ref-type="bibr">Kealy et&#x000a0;al. 2002</xref>; <xref rid="R35" ref-type="bibr">Mlacnik et&#x000a0;al. 2006</xref>). The anti-inflammatory effect is&#x000a0;specific for NSAIDs because they act by&#x000a0;inhibiting the cyclooxygenase (COX) enzyme (<xref rid="R30" ref-type="bibr">KuKanich et&#x000a0;al. 2012</xref>). Cimicoxib (CX) is&#x000a0;a&#x000a0;NSAID characterised by&#x000a0;its high effectivity as&#x000a0;a&#x000a0;COX-2 inhibitor (<xref rid="R22" ref-type="bibr">Jeunesse et&#x000a0;al. 2013</xref>; <xref rid="R27" ref-type="bibr">Kim et&#x000a0;al. 2014</xref>).</p><p>Glucosamine and chondroitin sulphate are used to&#x000a0;manage OA-induced painfulness (<xref rid="R40" ref-type="bibr">Peal et&#x000a0;al. 2007</xref>; <xref rid="R48" ref-type="bibr">Steagall et&#x000a0;al. 2007</xref>; <xref rid="R15" ref-type="bibr">Gupta et&#x000a0;al. 2012</xref>; <xref rid="R53" ref-type="bibr">Vassalotti et&#x000a0;al. 2017</xref>).</p><p>Autologous conditioned plasma (ACP) is&#x000a0;a&#x000a0;biological product consisting of&#x000a0;an&#x000a0;autogenous fluid containing a&#x000a0;supraphysiological concentration of&#x000a0;platelets (<xref rid="R16" ref-type="bibr">Harrison and Subcommittee on&#x000a0;Platelet Physiology 2018</xref>; <xref rid="R11" ref-type="bibr">Collins et&#x000a0;al. 2021</xref>). The platelets contain numerous growth factors that play an&#x000a0;important role in&#x000a0;the proliferation and differentiation of&#x000a0;stem cells, and also in&#x000a0;inducing healing processes (<xref rid="R39" ref-type="bibr">Pavlovic et&#x000a0;al. 2016</xref>; <xref rid="R42" ref-type="bibr">Qian et&#x000a0;al. 2017</xref>). Clinical studies in&#x000a0;both human and veterinary medicine, have shown promising results that ACP might be&#x000a0;beneficial in&#x000a0;the treatment of&#x000a0;various ligament pathologies of&#x000a0;traumatic and degenerative origin (<xref rid="R56" ref-type="bibr">Xie et&#x000a0;al. 2013</xref>; <xref rid="R26" ref-type="bibr">Kia et&#x000a0;al. 2018</xref>; <xref rid="R24" ref-type="bibr">Kaux et&#x000a0;al. 2020</xref>).</p><p>To the best of&#x000a0;the authors&#x02019; knowledge, there are no&#x000a0;reports evaluating the differences in&#x000a0;the MMP-3 serum concentrations and the clinical outcomes of&#x000a0;CrCLR in&#x000a0;dogs managed with ACP injections compared to&#x000a0;NSAIDs. The primary aim of&#x000a0;this research was to&#x000a0;evaluate the impact of&#x000a0;two management protocols (a&#x000a0;single intra-articular injection of&#x000a0;ACP and 14&#x000a0;days of&#x000a0;oral NSAID administration) for CrCLR on&#x000a0;the serum MMP-3&#x000a0;levels and the clinical outcomes in&#x000a0;cases of&#x000a0;unilateral CrCLR. Based on&#x000a0;the available published evidence, our hypothesis was that the serum MMP-3&#x000a0;levels would decrease in&#x000a0;the cases of&#x000a0;the CrCLR treatment with both methods, even after 28&#x000a0;days. However, the clinical outcomes after 28&#x000a0;days from the start of&#x000a0;the treatment would be&#x000a0;more favourable for the patients treated with the intra-articular ACP injection.</p><sec id="s2"><title>MATERIAL AND METHODS</title><p>This study is&#x000a0;the part of&#x000a0;investigation carried on&#x000a0;in&#x000a0;the Dr. L. Kriau&#x0010d;eli&#x0016b;nas Small Animal Clinic and Biochemistry laboratory of&#x000a0;the Neuroscience Institute of&#x000a0;the Lithuanian University of&#x000a0;Health Sciences (LSMU) between September 2019 and December 2021 (<xref rid="R44" ref-type="bibr">Raulinaite et&#x000a0;al. 2023</xref>).</p><p>The procedures complied with the criteria given by&#x000a0;the Lithuanian animal welfare regulations (No.&#x000a0;B1-866, 2012; No.&#x000a0;XI-2271, 2012) and&#x000a0;the decree of&#x000a0;the director of&#x000a0;the State Food and Veterinary Service, the Republic of&#x000a0;Lithuania [No. B6-(1.9)-2103, 2020]. The owners of&#x000a0;the animals provided consent for the patients&#x02019; participation. The research was conducted in&#x000a0;compliance with the EU&#x000a0;legislation.</p><sec id="s2_1"><title>Animals</title><p>All the dogs matched the inclusion criteria, which included a&#x000a0;60-day period without the administration of&#x000a0;NSAIDs and glucosamine/chondroitin sulphate supplements prior to&#x000a0;admission. Additionally, physical, orthopaedic, and diagnostic imaging evaluations were conducted to&#x000a0;confirm CrCLR and to&#x000a0;rule out the presence of&#x000a0;any additional pathologies; each patient&#x02019;s body conditioning score (BCS) was evaluated at&#x000a0;d0&#x000a0;of&#x000a0;the research (<xref rid="R31" ref-type="bibr">Laflamme 1997</xref>). All the owners of&#x000a0;the enrolled dogs voluntarily opted for the non-surgical treatment option and were not blinded to&#x000a0;the treatment groups; all the animals were blindly assigned to&#x000a0;the treatment groups. All the dogs were diagnosed with CrCLR based on&#x000a0;the results of&#x000a0;the clinical, radiological, and ultrasound examinations. The dogs were divided into two groups for the study. The two groups of&#x000a0;dogs were treated for CrCLR with either ACP (CrCLR-1, <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;6) or&#x000a0;NSAIDs and supplements (CrCLR-2, <italic toggle="yes">n</italic>&#x000a0;=&#x000a0;6).</p><p>CrCLR-1&#x000a0;group: The group consisted of&#x000a0;six mixed-breed dogs, four females, and two males, with a&#x000a0;mean age of&#x000a0;3.2&#x000a0;&#x000b1; 1.2&#x000a0;years, a&#x000a0;mean weight of&#x000a0;18.2&#x000a0;&#x000b1; 5.13&#x000a0;kg, a&#x000a0;mean BCS of&#x000a0;4.2&#x000a0;&#x000b1; 0.75&#x000a0;points, and a&#x000a0;mean period of&#x000a0;lameness before the first visit of&#x000a0;3.67&#x000a0;&#x000b1; 2.2&#x000a0;days.</p><p>CrCLR-2&#x000a0;group: The group consisted of&#x000a0;six mixed-breed dogs, three females and three males, a&#x000a0;mean age of&#x000a0;3.35&#x000a0;&#x000b1; 1&#x000a0;years, a&#x000a0;mean weight of&#x000a0;17.82&#x000a0;&#x000b1; 4.57&#x000a0;kg, a&#x000a0;mean BCS of&#x000a0;4&#x000a0;&#x000b1; 0.89&#x000a0;points, and a&#x000a0;mean period of&#x000a0;lameness before the first visit of&#x000a0;3.17&#x000a0;&#x000b1;&#x000a0;1.72 days. Each dog of&#x000a0;this group was administered cimicoxib orally once per day for 14&#x000a0;days, with a&#x000a0;daily dosage of&#x000a0;2&#x000a0;mg/kg; additionally, these animals were given supplements (7.2&#x000a0;&#x003bc;g of&#x000a0;cyanocobalamin, 53.1&#x000a0;&#x003bc;g of&#x000a0;folic acid, 2.6&#x000a0;mg of&#x000a0;thiamine, 0.51&#x000a0;mg of&#x000a0;riboflavin, 1.68&#x000a0;mg of&#x000a0;pyridoxine, 2.26&#x000a0;mg of&#x000a0;niacin, 0.71&#x000a0;mg of&#x000a0;vitamin E, 55.5&#x000a0;mg of&#x000a0;calcium, 44.6&#x000a0;mg of&#x000a0;phosphorus, 52.5&#x000a0;mg of&#x000a0;omega nutrients, 225&#x000a0;mg of&#x000a0;glucosamine sulphate, 162&#x000a0;mg of&#x000a0;chondroitin sulphate, and 59.94&#x000a0;mg of&#x000a0;methylsulphonylmethane) orally every twenty-four hours for fourteen days, according to&#x000a0;the recommendations of&#x000a0;the manufacturer (Bob Martin, UK) in&#x000a0;the form of&#x000a0;tablets.</p><p>Clinical and orthopaedic examinations and a&#x000a0;blood analysis for the MMP-3&#x000a0;levels were performed in&#x000a0;each group three times: on&#x000a0;the day before the start of&#x000a0;treatment (d0), fourteen days after (d14), and twenty-eight days after the start of&#x000a0;treatment (d28). At&#x000a0;the start of&#x000a0;the study, the owners were informed about the activity management guidelines they were required to&#x000a0;adhere to&#x000a0;at&#x000a0;home. These guidelines prohibited the animals from engaging in&#x000a0;any intense activities and required only supervised walks with a&#x000a0;leash.</p><p>All the examinations in&#x000a0;this research were performed by&#x000a0;an&#x000a0;orthopaedic specialist that was not blinded to&#x000a0;both treated groups.</p></sec><sec id="s2_2"><title>Methods</title><sec id="s2_2_1"><title>MANUAL EXAMINATIONS</title><p>All the animals (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;12) underwent clinical and orthopaedic assessments three times: at&#x000a0;d0, d14, and d28. A&#x000a0;clinical examination was conducted to&#x000a0;evaluate the overall animal&#x02019;s health condition and was performed according to&#x000a0;<xref rid="R5" ref-type="bibr">Bragg et&#x000a0;al. (2015)</xref>. For the orthopaedic examination, the degree of&#x000a0;lameness (0&#x02013;5), the presence of&#x000a0;stifle effusion, the cranial tibial thrust test, and the painfulness of&#x000a0;joint manipulations were assessed. All the animals showed positive tibial thrust, indicating CrCLR. The painfulness of&#x000a0;joint manipulations was graded on&#x000a0;a&#x000a0;scale of&#x000a0;0 to&#x000a0;3, with 0 indicating no&#x000a0;pain and 3 indicating severe pain. All the evaluations were conducted and assessed by&#x000a0;the same veterinarian who was not blinded to&#x000a0;the treatment cohorts.</p></sec><sec id="s2_2_2"><title>RADIOLOGICAL EXAMINATION</title><p>The animals underwent general anaesthesia for the radiological assessment (<xref rid="R44" ref-type="bibr">Raulinaite et&#x000a0;al. 2023</xref>). The radiological evaluation was conducted one time at&#x000a0;d0&#x000a0;and was not performed continuously during the study period, where standard medio-lateral and cranio-caudal projections of&#x000a0;the stifle joint were performed. The radiological examination was conducted with the primary goal of&#x000a0;confirming the diagnosis of&#x000a0;CrCLR and ruling out any concurrent pathologies, such as&#x000a0;patellar luxation, fractures, and anomalies. Via the radiological examination, stifle joint effusion was confirmed or&#x000a0;ruled out, by&#x000a0;evaluating its presence in&#x000a0;the radiographs. Following the system of&#x000a0;stifle OA evaluation, 32&#x000a0;variables were evaluated for each stifle, and then an&#x000a0;overall OA score (1&#x02013;4) was calculated, where 1&#x000a0;refers to&#x000a0;as&#x000a0;no&#x000a0;OA, and 4&#x000a0;refers to&#x000a0;as&#x000a0;severe OA (<xref rid="R32" ref-type="bibr">Lazar et&#x000a0;al. 2005</xref>). Changes in&#x000a0;the bone density and integrity, patella axis, and anatomical normality of&#x000a0;the stifle joint and its&#x02019; elements were evaluated. No&#x000a0;animals were diagnosed with patellar luxation, bone fractures or&#x000a0;stifle anomalies.</p></sec><sec id="s2_2_3"><title>ULTRASOUND</title><p>An ultrasound examination was conducted on&#x000a0;the affected stifle joint at&#x000a0;three time points: d0, d14, and d28. The primary objective of&#x000a0;the ultrasound examination was to&#x000a0;evaluate the meniscus damage. The methodology employed was in&#x000a0;accordance with the approach described by&#x000a0;<xref rid="R33" ref-type="bibr">Mahn et&#x000a0;al. (2005)</xref>.</p></sec><sec id="s2_2_4"><title>FOLLOW-UP</title><p>A&#x000a0;follow-up consisted of&#x000a0;completing a&#x000a0;modified force plate validated questionnaire (<xref rid="R19" ref-type="bibr">Hudson et&#x000a0;al. 2004</xref>). The questionnaire was completed during the follow-up visits. Veterinarians interviewed the dog&#x02019;s owners and recorded their answers three times: at&#x000a0;d0, d14, and d28. The owners were questioned regarding their dog&#x02019;s function before and after the ACP injection/NSAIDs administration. A&#x000a0;scale of&#x000a0;1 to&#x000a0;6 was selected (1&#x000a0;=&#x000a0;worse, 6&#x000a0;=&#x000a0;best) and used in&#x000a0;this study to&#x000a0;respond to&#x000a0;each question of&#x000a0;the questionnaire (<xref rid="R29" ref-type="bibr">Kishi and Hulse 2016</xref>). The questionnaire is&#x000a0;presented in&#x000a0;<xref rid="T1" ref-type="table">Table&#x000a0;1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><title>The follow-up questionnaire for evaluating the patient&#x02019;s mobility and quality of&#x000a0;life</title></caption><table frame="hsides" rules="groups"><col width="20%" span="1"/><col width="80%" span="1"/><tbody><tr><td valign="middle" align="left" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">#</td><td valign="middle" align="left" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">Question</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">1.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;the willingness to&#x000a0;play voluntarily?</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">2.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;the overall activity during the day?</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">3.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;the stiffness at&#x000a0;the start of&#x000a0;the day?</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">4.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;the stiffness at&#x000a0;the end of&#x000a0;the day?</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">5.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;an&#x000a0;indication of&#x000a0;lameness while walking?</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">6.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;the difficulty in&#x000a0;sitting down?</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">7.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;the difficulty of&#x000a0;laying down?</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">8.</td><td valign="middle" align="left" rowspan="1" colspan="1">What is&#x000a0;the difficulty in&#x000a0;rising up?</td></tr><tr><td valign="middle" align="left" style="border-bottom: solid 2pt" rowspan="1" colspan="1">9.</td><td valign="middle" align="left" style="border-bottom: solid 2pt" rowspan="1" colspan="1">What are the changes in&#x000a0;the amount of&#x000a0;engaging in&#x000a0;other activities?</td></tr></tbody></table></table-wrap></sec><sec id="s2_2_5"><title>BLOOD TESTING</title><p>The whole blood testing and blood biochemistry testing (for concentrations of&#x000a0;glucose, creatinine, urea, total protein, albumin, globulin, alanine aminotransferase, and alkaline phosphatase) were performed for all the animals at&#x000a0;d0&#x000a0;as&#x000a0;a&#x000a0;screening method to&#x000a0;exclude unhealthy dogs.</p></sec><sec id="s2_2_6"><title>AUTOLOGOUS CONDITIONED PLASMA</title><p>Each dog in&#x000a0;the CrCLR-1&#x000a0;group underwent general anaesthesia for the purpose of&#x000a0;the preparation and administration of&#x000a0;the ACP (<xref rid="R44" ref-type="bibr">Raulinaite et&#x000a0;al. 2023</xref>). The blood samples used for the ACP were prepared and administered by&#x000a0;orthopaedic specialist using an&#x000a0;ACP double syringe system (Arthrex, Inc., Naples, FL). The dose of&#x000a0;ACP was 2&#x000a0;ml and was aseptically injected into the affected stifle joint one time at&#x000a0;d0.</p></sec><sec id="s2_2_7"><title>ELISA</title><p>Peripheral blood samples (4&#x000a0;ml) were collected and prepared three times: at&#x000a0;d0, d14, and d28 (<xref rid="R44" ref-type="bibr">Raulinaite et&#x000a0;al. 2023</xref>). The concentrations of&#x000a0;MMP-3 in&#x000a0;the dog serum samples were measured using an&#x000a0;antibody-based, sandwich enzyme-linked, immunosorbent assay (ELISA) kit (Abbexa<sup>&#x000ae;</sup>, USA) strictly following the manufacturer&#x02019;s recommended procedures. Absorbance readings were performed at&#x000a0;450&#x000a0;nm. All the data were expressed as&#x000a0;mean&#x000a0;&#x000b1; standard deviation (SD).</p></sec><sec id="s2_2_8"><title>STATISTICAL ANALYSIS</title><p>A&#x000a0;statistical analysis was performed using the IBM SPSS Statistics<sup>&#x000ae;</sup> software program. The chi-square test, Kruskal-Wallis test, and the Mann-Whitney <italic toggle="yes">U</italic>&#x000a0;test were used to&#x000a0;evaluate the data. The level of&#x000a0;significance was set at&#x000a0;<italic toggle="yes">P</italic>&#x000a0;&#x0003c;&#x000a0;0.05.</p></sec></sec></sec><sec id="s3"><title>RESULTS</title><sec id="s3_1"><title>Groups</title><p>The statistical analysis showed that the CrCLR-1 and CrCLR-2&#x000a0;groups were homogenous. The results showed that the age, weight, BCS, and duration of&#x000a0;lameness before the first visit did not differ between the groups (<italic toggle="yes">P</italic>&#x000a0;&#x0003e;&#x000a0;0.05).</p></sec><sec id="s3_2"><title>Radiological examination</title><p>Stifle effusion was diagnosed in&#x000a0;all the animals of&#x000a0;the CrCLR-1 (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;6) and CrCLR-2 (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;6) groups.</p><p>The degree of&#x000a0;OA&#x000a0;in&#x000a0;the CrCLR-1&#x000a0;group was 2.3&#x000a0;&#x000b1; 0.82, and the OA degree in&#x000a0;the CrCLR-2&#x000a0;group was 2.17&#x000a0;&#x000b1; 0.75. The statistical analysis revealed no&#x000a0;statistically significant correlation between the OA and the MMP-3&#x000a0;levels, degree of&#x000a0;lameness, painfulness of&#x000a0;manipulations, and follow-up scores in&#x000a0;either the CrCLR-1 or&#x000a0;CrCLR-2&#x000a0;group.</p></sec><sec id="s3_3"><title>An ultrasound examination</title><p>The ultrasonographic evaluation revealed that 33.3% (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;2) of&#x000a0;the dogs in&#x000a0;the CrCLR-1&#x000a0;group had a&#x000a0;damaged medial meniscus at&#x000a0;d0, while 16.61% (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;1) of&#x000a0;the dogs in&#x000a0;the CrCLR-2&#x000a0;group exhibited the same pathology. These findings remained consistent at&#x000a0;d0, d14, and d28.</p></sec><sec id="s3_4"><title>MMP-3 concentration</title><p>The statistical analysis revealed a&#x000a0;significant difference between the CrCLR-1 and CrCLR-2&#x000a0;groups at&#x000a0;d28 (<italic toggle="yes">P</italic>&#x000a0;&#x0003c;&#x000a0;0.05). The results indicated that the MMP-3&#x000a0;levels of&#x000a0;the patients treated with ACP were more than two times lower at&#x000a0;d28 when compared to&#x000a0;d0. The MMP-3&#x000a0;levels did not differ between the groups at&#x000a0;d0&#x000a0;and d14 (<italic toggle="yes">P</italic>&#x000a0;&#x0003e;&#x000a0;0.05) (<xref rid="T2" ref-type="table">Table&#x000a0;2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><title>The results of&#x000a0;the MMP-3&#x000a0;levels of&#x000a0;the differently treated CrCLR groups</title></caption><table frame="hsides" rules="groups"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><tbody><tr><td valign="middle" align="left" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">Parameter</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">Group</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d0</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d14</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d28</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">MMP-3 concentration</td><td valign="middle" align="center" rowspan="1" colspan="1">CrCLR-1</td><td valign="middle" align="center" rowspan="1" colspan="1">52.43&#x000a0;&#x000b1; 36.44</td><td valign="middle" align="center" rowspan="1" colspan="1">33.11&#x000a0;&#x000b1; 18.1</td><td valign="middle" align="center" rowspan="1" colspan="1">11.62&#x000a0;&#x000b1; 5.81<sup>a</sup></td></tr><tr><td valign="middle" align="left" style="border-bottom: solid 2pt" rowspan="1" colspan="1">(ng/ml)</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">CrCLR-2</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">49.38&#x000a0;&#x000b1; 31.9</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">31.1&#x000a0;&#x000b1; 19.65</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">25.21&#x000a0;&#x000b1; 13.74<sup>a</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Changes in&#x000a0;the MMP-3 concentrations between the CrCLR groups at&#x000a0;d28 (<italic toggle="yes">P</italic><bold>&#x000a0;&#x0003c;&#x000a0;</bold>0.05)</p><p>d = day of treatment; CrCLR = cranial cruciate ligament rupture; MMP-3 = matrix metalloproteinease-3</p></table-wrap-foot></table-wrap></sec><sec id="s3_5"><title>Degree of&#x000a0;lameness</title><p>A&#x000a0;significant difference was revealed between the degree of&#x000a0;lameness of&#x000a0;the CrCLR-1 and CrCLR-2&#x000a0;groups at&#x000a0;d14 (<italic toggle="yes">P</italic>&#x000a0;&#x0003c;&#x000a0;0.05), and at&#x000a0;d28 (<italic toggle="yes">P</italic>&#x000a0;=&#x000a0;0.025). At&#x000a0;d14, the degree of&#x000a0;lameness was reduced in&#x000a0;both groups compared to&#x000a0;d0, but, at&#x000a0;d28, the patients treated with ACP continued to&#x000a0;display a&#x000a0;very low level or&#x000a0;no&#x000a0;degree of&#x000a0;lameness, while patients treated with NSAIDs had recurrent lameness (<xref rid="T3" ref-type="table">Table&#x000a0;3</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><title>The results of&#x000a0;the degree of&#x000a0;lameness of&#x000a0;the differently treated CrCLR groups</title></caption><table frame="hsides" rules="groups"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><tbody><tr><td valign="middle" align="left" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">Parameter</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">Group</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d0</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d14</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d28</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Degree of&#x000a0;lameness</td><td valign="middle" align="center" rowspan="1" colspan="1">CrCLR-1</td><td valign="middle" align="center" rowspan="1" colspan="1">4.66&#x000a0;&#x000b1; 0.52</td><td valign="middle" align="center" rowspan="1" colspan="1">1.83&#x000a0;&#x000b1; 0.75<sup>a</sup></td><td valign="middle" align="center" rowspan="1" colspan="1">0.17&#x000a0;&#x000b1; 0.41<sup>b</sup></td></tr><tr><td valign="middle" align="left" style="border-bottom: solid 2pt" rowspan="1" colspan="1">(0&#x02013;5)</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">CrCLR-2</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">4.17&#x000a0;&#x000b1; 0.75</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">0.33&#x000a0;&#x000b1; 0.52<sup>a</sup></td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">2.0&#x000a0;&#x000b1; 0.89<sup>b</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Changes in&#x000a0;the degree of&#x000a0;lameness between the CrCLR groups at&#x000a0;d14 (<italic toggle="yes">P</italic><bold>&#x000a0;&#x0003c;&#x000a0;</bold>0.05); <sup>b</sup>Changes in&#x000a0;the degree of&#x000a0;lameness between the CrCLR groups at&#x000a0;d28 (<italic toggle="yes">P</italic><bold>&#x000a0;&#x0003c;&#x000a0;</bold>0.05)</p><p>d = day of treatment; CrCLR = cranial cruciate ligament rupture</p></table-wrap-foot></table-wrap><p>The statistical analysis revealed no&#x000a0;statistically significant correlation between the degree of&#x000a0;lameness and the MMP-3&#x000a0;serum levels.</p></sec><sec id="s3_6"><title>Painfulness of&#x000a0;manipulations</title><p>A&#x000a0;statistical comparison between the painfulness of&#x000a0;the manipulation scores of&#x000a0;the CrCLR-1 and CrCLR-2&#x000a0;groups revealed a&#x000a0;highly significant difference at&#x000a0;d28 between the groups (<italic toggle="yes">P</italic>&#x000a0;&#x0003c;&#x000a0;0.01). At&#x000a0;this time point, patients treated with ACP showed almost ten times lower scores of&#x000a0;painfulness during the orthopaedic manipulations (<xref rid="T4" ref-type="table">Table&#x000a0;4</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><title>The results of&#x000a0;the painfulness of&#x000a0;the manipulations of&#x000a0;the differently treated CrCLR groups</title></caption><table frame="hsides" rules="groups"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><tbody><tr><td valign="middle" align="left" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">Parameter</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">Group</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d0</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d14</td><td valign="middle" align="center" style="border-top: solid 2pt; border-bottom: solid 1.4pt" rowspan="1" colspan="1">d28</td></tr><tr><td valign="middle" align="left" rowspan="1" colspan="1">Painfulness of&#x000a0;mani-</td><td valign="middle" align="center" rowspan="1" colspan="1">CrCLR-1</td><td valign="middle" align="center" rowspan="1" colspan="1">2.67&#x000a0;&#x000b1; 0.52</td><td valign="middle" align="center" rowspan="1" colspan="1">0.5&#x000a0;&#x000b1; 0.55</td><td valign="middle" align="center" rowspan="1" colspan="1">0.17 &#x000b1; 0.41<sup>a</sup></td></tr><tr><td valign="middle" align="left" style="border-bottom: solid 2pt" rowspan="1" colspan="1">pulations (1&#x02013;3)</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">CrCLR-2</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">3.0&#x000a0;&#x000b1; 0.00<sup>a</sup></td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">0.67&#x000a0;&#x000b1; 0.82</td><td valign="middle" align="center" style="border-bottom: solid 2pt" rowspan="1" colspan="1">1.67 &#x000b1; 0.52<sup>a</sup></td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Changes in&#x000a0;the painfulness of&#x000a0;the manipulations between the CrCLR groups at&#x000a0;d28 (<italic toggle="yes">P</italic><bold>&#x000a0;&#x0003c;&#x000a0;</bold>0.01)</p><p>d = day of treatment; CrCLR = cranial cruciate ligament rupture</p></table-wrap-foot></table-wrap></sec><sec id="s3_7"><title>Follow-up</title><p>All the animal owners responded to&#x000a0;all the questionnaire items, indicating their ratings on&#x000a0;a&#x000a0;1&#x02013;6&#x000a0;scale, with 1 representing the worst possible result and 6&#x000a0;representing the best possible result. The statistical analysis revealed that, at&#x000a0;d14, the mean follow-up score of&#x000a0;the quality of&#x000a0;life of&#x000a0;the CrCLR-1&#x000a0;group&#x000a0;was 16.6 % lower than that of&#x000a0;the&#x000a0;CrCLR-2&#x000a0;group; these differences were statistically significant (<italic toggle="yes">P</italic><bold>&#x000a0;&#x0003c;&#x000a0;</bold>0.01). At&#x000a0;d28, the mean follow-up score of&#x000a0;the quality of&#x000a0;life of&#x000a0;the CrCLR-1&#x000a0;group became higher (5.96&#x000a0;&#x000b1; 0.06), while the mean follow-up score of&#x000a0;the CrCLR-2&#x000a0;group decreased (4.24&#x000a0;&#x000b1; 0.35); these differences at&#x000a0;d28 were statistically significant (<italic toggle="yes">P</italic><bold>&#x000a0;&#x0003c;&#x000a0;</bold>0.01). A&#x000a0;statistical evaluation of&#x000a0;the data, presented as&#x000a0;the mean of&#x000a0;the entire questionnaire at&#x000a0;d0, d14, and d28, revealed a&#x000a0;continuous increase in&#x000a0;the follow-up score within a&#x000a0;group of&#x000a0;the CrCLR cases treated with ACP (<xref rid="F1" ref-type="fig">Figure&#x000a0;1</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><title>The impact of&#x000a0;the different treatments on&#x000a0;the follow-up scores (the mean values) at&#x000a0;three time points (d0, d14, and d28)</title></caption><graphic xlink:href="VETMED-70-04-124039-g001" position="float"/></fig></sec></sec><sec id="s4"><title>DISCUSSION</title><p>One of&#x000a0;the most prevalent causes of&#x000a0;stifle instability and OA in&#x000a0;dogs is&#x000a0;CrCLR (<xref rid="R54" ref-type="bibr">Vasseur and Berry 1992</xref>). Amongst new treatment modalities, ACP contains various growth factors and is&#x000a0;a&#x000a0;promising healing modality for damaged cartilages and ligaments both in&#x000a0;the human and veterinary medicine fields (<xref rid="R3" ref-type="bibr">Billinghurst et&#x000a0;al. 1997</xref>; <xref rid="R2" ref-type="bibr">Arnoczky et&#x000a0;al. 2011</xref>; <xref rid="R7" ref-type="bibr">Canapp et&#x000a0;al. 2016</xref>; <xref rid="R36" ref-type="bibr">Moussa et&#x000a0;al. 2017</xref>; <xref rid="R24" ref-type="bibr">Kaux et&#x000a0;al. 2020</xref>; <xref rid="R52" ref-type="bibr">Vander Doelen and Jelley 2020</xref>). The biomarker MMP-3 plays an&#x000a0;important role in&#x000a0;processes affecting connective tissue matrix during growth. Abnormal MMP-3 production causes cartilage matrix degeneration during OA (<xref rid="R38" ref-type="bibr">Panula et&#x000a0;al. 1998</xref>; <xref rid="R47" ref-type="bibr">Sondergaard et&#x000a0;al. 2010</xref>). There is&#x000a0;a&#x000a0;lack of&#x000a0;research comparing ACP and other canine CrCLR treatment modalities, their clinical outcomes, and impact on&#x000a0;changes in&#x000a0;the MMP-3&#x000a0;levels. This study compared the changes in&#x000a0;the MMP-3&#x000a0;serum levels and the clinical outcomes between canine CrCLR cases treated by&#x000a0;ACP injection or&#x000a0;NSAIDs, by&#x000a0;performing ELISA testing, orthopaedic examinations, and managing follow-up questionnaires before starting the initial treatment (d0), fourteen days after start of&#x000a0;the treatment (d14), and twenty-eight days after the start of&#x000a0;the treatment (d28). The results of&#x000a0;the study support the hypothesis regarding the decline in&#x000a0;the MMP-3&#x000a0;serum levels in&#x000a0;dogs up to&#x000a0;28 days following treatment with both management procedures. Furthermore, the results demonstrate that the benefits to&#x000a0;the dogs&#x02019; mobility and clinical outcomes are significantly higher when using a&#x000a0;single injection of&#x000a0;ACP versus NSAID management up to&#x000a0;14 days following the CrCLR with more sustained and higher benefits to&#x000a0;the mobility and observed clinical outcomes. To&#x000a0;the best of&#x000a0;our knowledge, this is&#x000a0;the first study to&#x000a0;examine the effects of&#x000a0;ACP injection vs oral NSAIDs on&#x000a0;the serum MMP-3&#x000a0;levels and the clinical outcomes in&#x000a0;the treatment of&#x000a0;canine CrCLR.</p><p>The results of&#x000a0;this study demonstrated significant changes in&#x000a0;the serum MMP-3&#x000a0;levels in&#x000a0;dogs with CrCLR treated with ACP injections and NSAIDs. As&#x000a0;described in&#x000a0;human medicine research, ACP has anti-inflammatory effects affecting the chondrocytes during OA (<xref rid="R51" ref-type="bibr">Unemori et&#x000a0;al. 1991</xref>). Osteoarthritis negatively affects the articular matrix whose mechanism is&#x000a0;associated with the MMP-3 action (<xref rid="R50" ref-type="bibr">Tchetina 2011</xref>; <xref rid="R28" ref-type="bibr">Kim 2019</xref>). The&#x000a0;results of&#x000a0;the significant differences between the MMP-3&#x000a0;serum levels at&#x000a0;d14 and d28 in&#x000a0;the cases of&#x000a0;the CrCLR-treated canines with ACP indicate that ACP has a&#x000a0;protective function on&#x000a0;the articular matrix, with this effect lasting up to&#x000a0;d28. On&#x000a0;the contrary, the MMP-3&#x000a0;serum levels in&#x000a0;dogs treated by&#x000a0;oral NSAIDs were almost two times higher, indicating that ACP is&#x000a0;more effective than NSAIDs in&#x000a0;managing joint inflammation caused by&#x000a0;CrCLR at&#x000a0;d28. Additionally, the dogs that were treated with oral NSAIDs were administered a&#x000a0;mixed supplement which can affect the cartilage and the joint environment. In&#x000a0;the present study, it&#x000a0;was detected that the serum MMP-3&#x000a0;levels of&#x000a0;the canine CrCLR cases, treated by&#x000a0;NSAIDs or&#x000a0;ACP, decreased similarly in&#x000a0;both groups up to&#x000a0;d14; the main difference was revealed at&#x000a0;d28 when the MMP-3&#x000a0;levels of&#x000a0;the dogs treated by&#x000a0;ACP decreased drastically. <xref rid="R28" ref-type="bibr">Kim et&#x000a0;al. (2019)</xref> found that the mRNA expression levels of&#x000a0;MMP-3 in&#x000a0;dogs&#x02019; chondrocytes were lower after using ACP, but the effect was not measured over a&#x000a0;longer period. To&#x000a0;the author&#x02019;s knowledge, this is&#x000a0;the first research to&#x000a0;measure the MMP-3&#x000a0;serum levels in&#x000a0;canines with diagnosed CrCLR at&#x000a0;three different time points in&#x000a0;a&#x000a0;span of&#x000a0;twenty-eight days, across a&#x000a0;range of&#x000a0;different treatment modalities. The present study was not sufficiently powered to&#x000a0;evaluate the correlation between the different degrees of&#x000a0;OA&#x000a0;and the selected treatment methods. This was due to&#x000a0;the small number of&#x000a0;patients in&#x000a0;the groups and the limited range of&#x000a0;OA&#x000a0;degrees. These data may contribute to&#x000a0;a&#x000a0;more comprehensive understanding of&#x000a0;the management of&#x000a0;inflammatory processes in&#x000a0;the stifle joint.</p><p>Painfulness and the associated lameness can be&#x000a0;caused by&#x000a0;OA&#x000a0;(<xref rid="R55" ref-type="bibr">Vilar et&#x000a0;al. 2018</xref>). In&#x000a0;this study, the clinical outcomes were assessed by&#x000a0;lameness scores, and the painfulness of&#x000a0;manipulation scores at&#x000a0;d0, d14, and d28. The evaluations were noted for all the dogs (<italic toggle="yes">n</italic> = 12) in&#x000a0;the study. The data indicate that, in&#x000a0;the cases of&#x000a0;CrCLR treated with a&#x000a0;single intra-articular injection of&#x000a0;ACP, the lameness scores decreased up to&#x000a0;28 days, whereas, in&#x000a0;the animals treated with oral NSAIDs, the lameness scores decreased up to&#x000a0;14 days, with a&#x000a0;recurrence of&#x000a0;lameness at&#x000a0;d28.</p><p>It is&#x000a0;important to&#x000a0;note that the administration of&#x000a0;NSAIDs for up to&#x000a0;14 days proved to&#x000a0;be&#x000a0;more advantageous in&#x000a0;terms of&#x000a0;the clinical outcomes. The reduction of&#x000a0;this effect was observed only subsequent to&#x000a0;this period when the NSAID usage was terminated. These results can be&#x000a0;affected not only by&#x000a0;the short-term activity of&#x000a0;NSAIDs, but also by&#x000a0;additional factors, such as&#x000a0;the increased animals&#x02019; activity due to&#x000a0;the improved clinical outcomes and less painfulness. In&#x000a0;this case, the usage of&#x000a0;NSAIDs may result in&#x000a0;better clinical outcomes for up to&#x000a0;14 days, but this may also lead to&#x000a0;a&#x000a0;higher load to&#x000a0;the limb and secondary damage to&#x000a0;the joint. It&#x000a0;should be&#x000a0;noted that the same additional factors can also affect the results of&#x000a0;the group treated&#x000a0;by&#x000a0;ACP.</p><p>The research indicated that no&#x000a0;additional damage to&#x000a0;the meniscus was sustained over the 28-day period, suggesting that the secondary damage to&#x000a0;the stifle joint was unlikely. However, the short-term action of&#x000a0;the NSAIDs may provide a&#x000a0;valid explanation for the sudden worsening in&#x000a0;clinical outcomes after 14 days in&#x000a0;the group treated with NSAIDs.</p><p><xref rid="R8" ref-type="bibr">Catarino et&#x000a0;al. (2020)</xref> performed a&#x000a0;gait analysis after four leukocyte-reduced ACP injections in&#x000a0;canine CrCLR cases over three months and obtained results indicating improvement in&#x000a0;the gait (<xref rid="R8" ref-type="bibr">Catarino et&#x000a0;al. 2020</xref>). Our results of&#x000a0;the painfulness of&#x000a0;manipulation revealed a&#x000a0;significant improvement in&#x000a0;the patients treated with ACP. The patients treated with NSAIDs showed recurrent reactions to&#x000a0;manipulations at&#x000a0;d28, while those who were treated with ACP demonstrated minimal pain. Although our results revealed a&#x000a0;significant reduction in&#x000a0;the painfulness for dogs with CrCLR, the magnitude of&#x000a0;this decline was greater in&#x000a0;those treated with ACP than with NSAIDs at&#x000a0;d28. <xref rid="R8" ref-type="bibr">Catarino et&#x000a0;al. (2020)</xref> found out that ninety days after a&#x000a0;single intra-articular ACP injection, the dogs were almost pain-free. Our results show that outcomes on&#x000a0;lameness and painfulness of&#x000a0;manipulations after the single intra-articular ACP injection are specified by&#x000a0;longer-term lasting effects in&#x000a0;comparison to&#x000a0;the usage of&#x000a0;NSAIDs.</p><p>There is&#x000a0;a&#x000a0;lack of&#x000a0;significant data supporting the ACP effects to&#x000a0;the overall patient&#x02019;s general activity and quality of&#x000a0;life. Follow-up questions, evaluating the patient&#x02019;s mobility and quality of&#x000a0;life, were collected from all the patient&#x02019;s owners (<italic toggle="yes">n</italic> = 12) at&#x000a0;d0, d14, and d28. To&#x000a0;the best of&#x000a0;our knowledge, this is&#x000a0;the first study assessing the mentioned variables in&#x000a0;dogs suffering from CrCLR. <xref rid="R43" ref-type="bibr">Raeissadat et&#x000a0;al. (2021)</xref> researched the effects of&#x000a0;an&#x000a0;ACP injection on&#x000a0;the quality of&#x000a0;life in&#x000a0;humans with stifle OA and obtained results showing that ACP increased the patients&#x02019; quality of&#x000a0;life. Our results revealed significant changes in&#x000a0;the follow-up scores in&#x000a0;the cases of&#x000a0;canine CrCLR treated with ACP or&#x000a0;NSAIDs. The study results indicate that the treatment of&#x000a0;canine CrCLR with ACP improved the quality of&#x000a0;life and mobility in&#x000a0;dogs compared to&#x000a0;NSAIDs treatment after 28 days.</p><p>The present study is&#x000a0;not without limitations, including the small sample size, lack of&#x000a0;a&#x000a0;control group, absence of&#x000a0;tibial plateau angle measurements, low frequency of&#x000a0;the evaluations, and overall short follow-up period. Furthermore, neither the veterinarian nor the owners were blinded to&#x000a0;both treated groups.</p><p>Larger sample sizes, measurements of&#x000a0;the tibia plateau angle, more frequent follow-up intervals, and longer overall follow-up period, and a&#x000a0;randomised study design would enhance further studies and may facilitate a&#x000a0;better comprehension of&#x000a0;the effects of&#x000a0;ACP as&#x000a0;a&#x000a0;treatment modality for canine CrCLR. Nonetheless, we&#x000a0;believe that the findings of&#x000a0;this study may significantly contribute to&#x000a0;the further understanding of&#x000a0;the management of&#x000a0;canine orthopaedic diseases using novel treatment approaches.</p><p>The results of&#x000a0;our research indicate that a&#x000a0;single intra-articular ACP injection could be&#x000a0;an&#x000a0;effective and beneficial treatment method in&#x000a0;terms of&#x000a0;better clinical outcomes in&#x000a0;cases of&#x000a0;mild, moderate, and severe stifle OA caused by&#x000a0;CrCLR, showing an&#x000a0;extended duration of&#x000a0;efficacy, and management of&#x000a0;the inflammatory processes in&#x000a0;the affected stifle joint, in&#x000a0;contrast to&#x000a0;oral NSAIDs.</p><p>It can be&#x000a0;concluded that ACP, when administered once via injection into the stifle joint, has a&#x000a0;more advantageous impact on&#x000a0;the local inflammation of&#x000a0;the stifle joint, orthopaedic parameters, and animal mobility. Furthermore, it&#x000a0;has a&#x000a0;more prolonged duration of&#x000a0;action than oral NSAIDs in&#x000a0;the treatment of&#x000a0;canine CrCLR, lasting up to&#x000a0;twenty-eight days.</p></sec></body><back><sec sec-type="COI-statement" id="s5"><title>Conflict of&#x000a0;interest</title><p>The authors declare no&#x000a0;conflict of&#x000a0;interest.</p></sec><ref-list><title>REFERENCES</title><ref id="R1"><mixed-citation publication-type="journal"><string-name><surname>Alvarez</surname>
<given-names>LX</given-names></string-name>, <string-name><surname>Repac</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Kirkby Shaw</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Compton</surname>
<given-names>N</given-names></string-name>. <article-title>Systematic review of postoperative rehabilitation interventions after cranial cruciate ligament surgery in dogs</article-title>. <source>Vet Surg</source>. <year>2022 Feb</year>;<volume>51</volume>(<issue>2</issue>):<fpage>233</fpage>-<lpage>43</lpage>.<pub-id pub-id-type="pmid">35023182</pub-id>
</mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><string-name><surname>Arnoczky</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Delos</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rodeo</surname>
<given-names>SA</given-names></string-name>. <article-title>What is platelet-rich plasma? Oper Tech Sports Med</article-title>. <year>2011 Sep</year>;<volume>19</volume>(<issue>3</issue>):<fpage>142</fpage>-<lpage>8</lpage>.</mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><string-name><surname>Billinghurst</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Dahlberg</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ionescu</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Reiner</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bourne</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rorabeck</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Hambor</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Diekmann</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Tscheche</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Van Wart</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Poole</surname>
<given-names>AR</given-names></string-name>. <article-title>Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage</article-title>. <source>J Clin Invest</source>. <year>1997 Apr 1</year>;<volume>99</volume>(<issue>7</issue>):<fpage>1534</fpage>-<lpage>45</lpage>.<pub-id pub-id-type="pmid">9119997</pub-id>
</mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><string-name><surname>Bleedorn</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Greuel</surname>
<given-names>EN</given-names></string-name>, <string-name><surname>Manley</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Schaefer</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Markel</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Holzman</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Muir</surname>
<given-names>P</given-names></string-name>. <article-title>Synovitis in dogs with stable stifle joints and incipient cranial cruciate ligament rupture: A cross-sectional study</article-title>. <source>Vet Surg</source>. <year>2011 Jul</year>;<volume>40</volume>(<issue>5</issue>):<fpage>531</fpage>-<lpage>43</lpage>.<pub-id pub-id-type="pmid">21615432</pub-id>
</mixed-citation></ref><ref id="R5"><mixed-citation publication-type="journal"><string-name><surname>Bragg</surname>
<given-names>RF</given-names></string-name>, <string-name><surname>Bennett</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Cummings</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Quimby</surname>
<given-names>JM</given-names></string-name>. <article-title>Evaluation of the effects of hospital visit stress on physiologic variables in dogs</article-title>. <source>J Am Vet Med Assoc</source>. <year>2015 Jan 15</year>;<volume>246</volume>(<issue>2</issue>): <fpage>212</fpage>-<lpage>15</lpage>.<pub-id pub-id-type="pmid">25554937</pub-id>
</mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><string-name><surname>Brandt</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Myers</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Burr</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Albrecht</surname>
<given-names>M</given-names></string-name>. <article-title>Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament</article-title>. <source>Arthritis Rheum</source>. <year>1991 Dec</year>; <volume>34</volume>(<issue>12</issue>):<fpage>1560</fpage>-<lpage>71</lpage>.<pub-id pub-id-type="pmid">1747141</pub-id>
</mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><string-name><surname>Canapp</surname>
<given-names>SO</given-names></string-name>, <string-name><surname>Leasure</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Cox</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ibrahim</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Carr</surname>
<given-names>BJ</given-names></string-name>. <article-title>Partial cranial cruciate ligament tears treated with stem cell and platelet-rich plasma combination therapy in 36 dogs: A retrospective study</article-title>. <source>Front Vet Sci</source>. <year>2016 Dec 14</year>;<volume>3</volume>:<fpage>112</fpage>.<pub-id pub-id-type="pmid">28018908</pub-id>
</mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><string-name><surname>Catarino</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Carvalho</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Santos</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Martins</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Requichal</surname>
<given-names>J</given-names></string-name>. <article-title>Treatment of canine osteoarthritis with allogeneic platelet-rich plasma: Review of five cases</article-title>. <source>Open Vet J</source>. <year>2020 Apr-Jun</year>;<volume>10</volume>(<issue>2</issue>):<fpage>226</fpage>-<lpage>31</lpage>.<pub-id pub-id-type="pmid">32821667</pub-id>
</mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><string-name><surname>Chauvet</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Pijanowski</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Homcko</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>RD</given-names></string-name>. <article-title>Evaluation of fibular head transposition, lateral fabellar suture, and conservative treatment of cranial cruciate ligament rupture in large dogs: A retrospective study</article-title>. <source>J Am Anim Hosp Assoc</source>. <year>1996 May-Jun</year>;<volume>32</volume>:<fpage>247</fpage>-<lpage>55</lpage>.<pub-id pub-id-type="pmid">8731140</pub-id>
</mixed-citation></ref><ref id="R10"><mixed-citation publication-type="journal"><string-name><surname>Clements</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Carter</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Innes</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Ollier</surname>
<given-names>WE</given-names></string-name>, <string-name><surname>Day</surname>
<given-names>PJ</given-names></string-name>. <article-title>Gene expression profiling of normal and ruptured canine anterior cruciate ligaments</article-title>. <source>Osteoarthr Cartil</source>. <year>2008 Feb</year>; <volume>16</volume>(<issue>2</issue>):<fpage>195</fpage>-<lpage>203</lpage>.</mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><string-name><surname>Collins</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Alexander</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Barkatali</surname>
<given-names>B</given-names></string-name>. <article-title>Autologous conditioned plasma: A narrative review</article-title>. <source>EFORT Open Rev</source>. <year>2021 Apr</year>; <volume>6</volume>(<issue>4</issue>):<fpage>225</fpage>-<lpage>35</lpage>.<pub-id pub-id-type="pmid">34040800</pub-id>
</mixed-citation></ref><ref id="R12"><mixed-citation publication-type="journal"><string-name><surname>Comerford</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Tarlton</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Innes</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Amis</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Bailey</surname>
<given-names>AJ</given-names></string-name>. <article-title>Metabolism and composition of the canine anterior cruciate ligament relate to differences in knee joint mechanics and predisposition to ligament rupture</article-title>. <source>J Orthop Res</source>. <year>2005 Jan</year>;<volume>23</volume>(<issue>1</issue>):<fpage>61</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">15607876</pub-id>
</mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><string-name><surname>De Gruttola</surname>
<given-names>VG</given-names></string-name>, <string-name><surname>Clax</surname>
<given-names>P</given-names></string-name>, <string-name><surname>DeMets</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Downing</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Ellenberg</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Friedman</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gail</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Prentice</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Wittes</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zeger</surname>
<given-names>SL</given-names></string-name>. <article-title>Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health workshop</article-title>. <source>Control Clin Trials</source>. <year>2001 Oct</year>;<volume>22</volume>(<issue>5</issue>): <fpage>485</fpage>-<lpage>502</lpage>.<pub-id pub-id-type="pmid">11578783</pub-id>
</mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><string-name><surname>Fernandes</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Martel-Pelletier</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pelletier</surname>
<given-names>JP</given-names></string-name>. <article-title>The role of cytokines in osteoarthritis pathophysiology</article-title>. <source>Biorheology</source>. <year>2002</year>;<volume>39</volume>(<issue>1-2</issue>):<fpage>237</fpage>-<lpage>46</lpage>.<pub-id pub-id-type="pmid">12082286</pub-id>
</mixed-citation></ref><ref id="R15"><mixed-citation publication-type="journal"><string-name><surname>Gupta</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Canerdy</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Lindley</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Konemann</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Minniear</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Carroll</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Hendrick</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Goad</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Rohde</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Doss</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bagchi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bagchi</surname>
<given-names>D</given-names></string-name>. <article-title>Comparative therapeutic efficacy and safety of type-II collagen (uc-II), glucosamine and chondroitin in arthritic dogs: Pain evaluation by ground force plate</article-title>. <source>J Anim Physiol Anim Nutr</source>. <year>2012 May 30</year>;<volume>96</volume>(<issue>5</issue>):<fpage>770</fpage>-<lpage>7</lpage>.</mixed-citation></ref><ref id="R16"><mixed-citation publication-type="journal"><string-name><surname>Harrison</surname>
<given-names>P</given-names></string-name>; <collab>Subcommittee on Platelet Physiology</collab>. <article-title>The use of platelets in regenerative medicine and proposal for a new classification system: Guidance from the SSC of the ISTH</article-title>. <source>J Thromb Haemost</source>. <year>2018 Sep</year>;<volume>16</volume>(<issue>9</issue>):<fpage>1895</fpage>-<lpage>900</lpage>.<pub-id pub-id-type="pmid">30099839</pub-id>
</mixed-citation></ref><ref id="R17"><mixed-citation publication-type="journal"><string-name><surname>Hayashi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Manley</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Muir</surname>
<given-names>P</given-names></string-name>. <article-title>Cranial cruciate ligament pathophysiology in dogs with cruciate disease: A review</article-title>. <source>J Am Anim Hosp Assoc</source>. <year>2004 Sep-Oct</year>;<volume>40</volume>(<issue>5</issue>):<fpage>385</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="pmid">15347618</pub-id>
</mixed-citation></ref><ref id="R18"><mixed-citation publication-type="journal"><string-name><surname>Hegemann</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Wondimu</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ullrich</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Schmidt</surname>
<given-names>MF</given-names></string-name>. <article-title>Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis</article-title>. <source>Vet Immunol Immunopathol</source>. <year>2003 Feb 10</year>;<volume>91</volume>(<issue>3-4</issue>): <fpage>199</fpage>-<lpage>204</lpage>.<pub-id pub-id-type="pmid">12586482</pub-id>
</mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><string-name><surname>Hudson</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Slater</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Kerwin</surname>
<given-names>S</given-names></string-name>. <article-title>Assessing repeatability and validity of a visual analogue scale questionnaire for use in assessing pain and lameness in dogs</article-title>. <source>Am J Vet Res</source>. <year>2004 Dec</year>;<volume>65</volume>(<issue>12</issue>):<fpage>1634</fpage>-<lpage>43</lpage>.<pub-id pub-id-type="pmid">15631027</pub-id>
</mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><string-name><surname>Innes</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Bacon</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Lynch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Pollard</surname>
<given-names>A</given-names></string-name>. <article-title>Long-term outcome of surgery for dogs with cranial cruciate ligament deficiency</article-title>. <source>Vet Rec</source>. <year>2000 Sep 16</year>;<volume>147</volume>(<issue>12</issue>):<fpage>325</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">11058021</pub-id>
</mixed-citation></ref><ref id="R21"><mixed-citation publication-type="journal"><string-name><surname>Innes</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Costello</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barr</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Rudorf</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Barr</surname>
<given-names>AR</given-names></string-name>. <article-title>Radiographic progression of osteoarthritis of the canine stifle joint: A prospective study</article-title>. <source>Vet Radiol Ultrasound</source>. <year>2004 Mar-Apr</year>;<volume>45</volume>(<issue>2</issue>):<fpage>143</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">15072147</pub-id>
</mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><string-name><surname>Jeunesse</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Woehrle</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Faucher</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lefebvre</surname>
<given-names>HP</given-names></string-name>, <string-name><surname>Toutain</surname>
<given-names>P</given-names></string-name>. <article-title>Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog</article-title>. <source>BMC Vet Res</source>. <year>2013 Dec 11</year>;<volume>9</volume>(<issue>1</issue>):<fpage>250</fpage>.<pub-id pub-id-type="pmid">24330630</pub-id>
</mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><string-name><surname>Johnson</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Austin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Breur</surname>
<given-names>GJ</given-names></string-name>. <article-title>Incidence of canine appendicular musculoskeletal disorders in 16 veterinary teaching hospitals from 1980 through 1989</article-title>. <source>Vet Comp Orthop Traumatol</source>. <year>1994 Feb</year>;<volume>7</volume>:<fpage>56</fpage>-<lpage>69</lpage>.</mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><string-name><surname>Kaux</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Libertiaux</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Dupont</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Colige</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Denoel</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lecut</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Hego</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gustin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Duwez</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Oury</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gothot</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Greimers</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Drion</surname>
<given-names>P</given-names></string-name>. <article-title>Platelet-rich plasma (PRP) and tendon healing: Comparison between fresh and frozen-thawed ACP</article-title>. <source>Platelets</source>. <year>2020</year>;<volume>31</volume>(<issue>2</issue>):<fpage>221</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="pmid">30915890</pub-id>
</mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><string-name><surname>Kealy</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Lawler</surname>
<given-names>DF</given-names></string-name>, <string-name><surname>Ballam</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Mantz</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Biery</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Greeley</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Lust</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Segre</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>GK</given-names></string-name>, <string-name><surname>Stowe</surname>
<given-names>HD</given-names></string-name>. <article-title>Effects of diet restriction on life span and age-related changes in dogs</article-title>. <source>J Am Anim Hosp Assoc</source>. <year>2002 May 1</year>;<volume>220</volume>(<issue>9</issue>): <fpage>1315</fpage>-<lpage>20</lpage>.</mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><string-name><surname>Kia</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Baldino</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bell</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ramji</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Uyeki</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Mazzocca</surname>
<given-names>A</given-names></string-name>. <article-title>Platelet-rich plasma: Review of current literature on its use for tendon and ligament pathology</article-title>. <source>Curr Rev Musculoskelet Med</source>. <year>2018 Dec</year>;<volume>11</volume>(<issue>4</issue>):<fpage>566</fpage>-<lpage>72</lpage>.<pub-id pub-id-type="pmid">30203334</pub-id>
</mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>TW</given-names></string-name>, <string-name><surname>Lebkowska-Wieruszewska</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Owen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Yun</surname>
<given-names>HI</given-names></string-name>, <string-name><surname>Kowalski</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Giorgi</surname>
<given-names>M</given-names></string-name>. <article-title>Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs</article-title>. <source>Vet J</source>. <year>2014 Apr</year>;<volume>200</volume>(<issue>1</issue>):<fpage>77</fpage>-<lpage>81</lpage>.<pub-id pub-id-type="pmid">24461644</pub-id>
</mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Jeong</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Kwon</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yun</surname>
<given-names>S</given-names></string-name>. <article-title>Platelet-rich plasma enhances proliferation and migration and inhibits inflammatory processes in canine chondrocytes</article-title>. <source>J Vet Clin</source>. <year>2019</year>;<volume>36</volume>(<issue>4</issue>):<fpage>200</fpage>-<lpage>6</lpage>.</mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><string-name><surname>Kishi</surname>
<given-names>EN</given-names></string-name>, <string-name><surname>Hulse</surname>
<given-names>D</given-names></string-name>. <article-title>Owner evaluation of a CORA-based leveling osteotomy for treatment of cranial cruciate ligament injury in dogs</article-title>. <source>Vet Surg</source>. <year>2016 May</year>;<volume>45</volume>(<issue>4</issue>):<fpage>507</fpage>-<lpage>14</lpage>.<pub-id pub-id-type="pmid">27041682</pub-id>
</mixed-citation></ref><ref id="R30"><mixed-citation publication-type="journal"><string-name><surname>KuKanich</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Bidgood</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Knesl</surname>
<given-names>O</given-names></string-name>. <article-title>Clinical pharmacology of nonsteroidal anti-inflammatory drugs in dogs</article-title>. <source>Vet Anaesth Analg</source>. <year>2012 Jan</year>;<volume>39</volume>(<issue>19</issue>):<fpage>69</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="pmid">22151877</pub-id>
</mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><string-name><surname>Laflamme</surname>
<given-names>DP</given-names></string-name>. <article-title>Development and validation of a body condition score system for dogs: A clinical tool</article-title>. <source>Canine Pract</source>. <year>1997</year>;<volume>22</volume>:<fpage>10</fpage>-<lpage>5</lpage>.</mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><string-name><surname>Lazar</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Berry</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Peck</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Correa</surname>
<given-names>M</given-names></string-name>. <article-title>Long-term radiographic comparison of tibial plateau leveling osteotomy versus extracapsular stabilization for cranial cruciate ligament rupture in the dog</article-title>. <source>Vet Surg</source>. <year>2005 Mar-Apr</year>; <volume>34</volume>(<issue>2</issue>):<fpage>133</fpage>-<lpage>41</lpage>.<pub-id pub-id-type="pmid">15860104</pub-id>
</mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><string-name><surname>Mahn</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Cook</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Cook</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Balke</surname>
<given-names>MT</given-names></string-name>. <article-title>Arthroscopic verification of ultrasonographic diagnosis of meniscal pathology in dogs</article-title>. <source>Vet Surg</source>. <year>2005 Jul-Aug</year>;<volume>34</volume>(<issue>4</issue>):<fpage>318</fpage>-<lpage>23</lpage>.<pub-id pub-id-type="pmid">16212585</pub-id>
</mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><string-name><surname>Martel-Pelletier</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Alaaeddine</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Pelletier</surname>
<given-names>JP</given-names></string-name>. <article-title>Cytokines and their role in the pathophysiology of osteoarthritis</article-title>. <source>Front Biosci</source>. <year>1999 Oct 15</year>;<volume>4</volume>:<fpage>694</fpage>-<lpage>703</lpage>.</mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><string-name><surname>Mlacnik</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bockstahler</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Muller</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Tetrick</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Nap</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Zentek</surname>
<given-names>J</given-names></string-name>. <article-title>Effects of caloric restriction and a moderate or intense physiotherapy program for treatment of lameness in overweight dogs with osteoarthritis</article-title>. <source>J Am Anim Hosp Assoc</source>. <year>2006 Dec 1</year>;<volume>229</volume>(<issue>11</issue>):<fpage>1756</fpage>-<lpage>60</lpage>.</mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><string-name><surname>Moussa</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lajeunesse</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Hilal</surname>
<given-names>G</given-names></string-name>, <string-name><surname>El Atat</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Haykal</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Serhal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chalhoub</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khalil</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Alaaeddine</surname>
<given-names>N</given-names></string-name>. <article-title>Platelet-rich plasma (PRP) induces chondroprotection via increasing autophagy, anti-inflammatory markers, and decreasing apoptosis in human osteoarthritic cartilage</article-title>. <source>Exp Cell Res</source>. <year>2017 Mar 1</year>;<volume>352</volume>(<issue>1</issue>):<fpage>146</fpage>-<lpage>56</lpage>.<pub-id pub-id-type="pmid">28202394</pub-id>
</mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><string-name><surname>Muir</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Danova</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Argyle</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Manley</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Hao</surname>
<given-names>Z</given-names></string-name>. <article-title>Collagenolytic protease expression in cranial cruciate ligament and stifle synovial fluid in dogs with cranial cruciate ligament rupture</article-title>. <source>Vet Surg</source>. <year>2005 Sep-Oct</year>;<volume>34</volume>(<issue>5</issue>):<fpage>482</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="pmid">16266341</pub-id>
</mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><string-name><surname>Panula</surname>
<given-names>HE</given-names></string-name>, <string-name><surname>Lohmander</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Ronkko</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Agren</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Helminen</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Kiviranta</surname>
<given-names>I</given-names></string-name>. <article-title>Elevated levels of synovial fluid PLA2, stromelysin (MMP-3) and TIMP in early osteoarthrosis after tibial valgus osteotomy in young beagle dogs</article-title>. <source>Acta Orthop Scand</source>. <year>1998 Apr</year>;<volume>69</volume>(<issue>2</issue>):<fpage>152</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">9602773</pub-id>
</mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><string-name><surname>Pavlovic</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ciric</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jovanovic</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Stojanovic</surname>
<given-names>P</given-names></string-name>. <article-title>Platelet-rich plasma: A short overview of certain bioactive components</article-title>. <source>Open Med (Wars)</source>. <year>2016</year>;<volume>11</volume>(<issue>1</issue>):<fpage>242</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">28352802</pub-id>
</mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><string-name><surname>Peal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>D&#x02018;Altilio</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Simms</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Curtsinger</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Canerdy</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Goad</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Bagchi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bagchi</surname>
<given-names>D</given-names></string-name>. <article-title>Therapeutic efficacy and safety of undenatured type-II collagen (UC-II) alone or in combination with (-)-hydroxycitric acid and Chromemate in arthritic dogs</article-title>. <source>J Vet Pharmacol Ther</source>. <year>2007 Jun</year>;<volume>30</volume>(<issue>3</issue>):<fpage>275</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">17472662</pub-id>
</mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><string-name><surname>Qi</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Changlin</surname>
<given-names>H</given-names></string-name>. <article-title>Levels of biomarkers correlate with magnetic resonance imaging progression of knee cartilage degeneration: A study on canine</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2007 Jul</year>;<volume>15</volume>(<issue>7</issue>):<fpage>869</fpage>-<lpage>78</lpage>.<pub-id pub-id-type="pmid">17641922</pub-id>
</mixed-citation></ref><ref id="R42"><mixed-citation publication-type="journal"><string-name><surname>Qian</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ouyang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Fan</surname>
<given-names>C</given-names></string-name>. <article-title>Platelet-rich plasma derived growth factors contribute to stem cell differentiation in musculoskeletal regeneration</article-title>. <source>Front Chem</source>. <year>2017 Oct</year>;<volume>31</volume>(<issue>5</issue>):<fpage>89</fpage>.</mixed-citation></ref><ref id="R43"><mixed-citation publication-type="journal"><string-name><surname>Raeissadat</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Rayegani</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Sohrabi</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Jafarian</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Bahrami</surname>
<given-names>MN</given-names></string-name>. <article-title>Effectiveness of intra-articular autologous-conditioned serum injection in knee osteoarthritis: A meta-analysis study</article-title>. <source>Future Sci OA</source>. <year>2021 Oct</year>;<volume>7</volume>(<issue>9</issue>).</mixed-citation></ref><ref id="R44"><mixed-citation publication-type="journal"><string-name><surname>Raulinaite</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Zelvyte</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Skemiene</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Burbaite</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Karveliene</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Monkeviciene</surname>
<given-names>I</given-names></string-name>. <article-title>The single intra-articular injection of platelet-rich plasma vs. non-steroidal anti-inflammatory drugs as treatment options for canine cruciate ligament rupture and patellar luxation</article-title>. <source>Vet Sci</source>. <year>2023 Sep 4</year>;<volume>10</volume> (<issue>9</issue>):<fpage>555</fpage>.<pub-id pub-id-type="pmid">37756077</pub-id>
</mixed-citation></ref><ref id="R45"><mixed-citation publication-type="journal"><string-name><surname>Rayward</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Thomson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Davies</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Innes</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Whitelock</surname>
<given-names>R</given-names></string-name>. <article-title>Progression of osteoarthritis following TPLO surgery: A prospective radiographic study of 40 dogs</article-title>. <source>J Small Anim Pract</source>. <year>2004 Feb</year>;<volume>45</volume>(<issue>2</issue>):<fpage>92</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">14984152</pub-id>
</mixed-citation></ref><ref id="R46"><mixed-citation publication-type="journal"><string-name><surname>Sellon</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Marcellin-Little</surname>
<given-names>DJ</given-names></string-name>. <article-title>Risk factors for cranial cruciate ligament rupture in dogs participating in canine agility</article-title>. <source>BMC Vet Res</source>. <year>2022 Jan</year>;<volume>18</volume>(<issue>1</issue>):<fpage>39</fpage>.<pub-id pub-id-type="pmid">35033070</pub-id>
</mixed-citation></ref><ref id="R47"><mixed-citation publication-type="journal"><string-name><surname>Sondergaard</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Schultz</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Madsen</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Bay-Jensen</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Kassem</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Karsdal</surname>
<given-names>MA</given-names></string-name>. <article-title>MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation: Divergence in pathways leading to aggrecanase and MMP mediated articular cartilage degradation</article-title>. <source>Osteoarthritis Cartilage</source>. <year>2010 Mar</year>;<volume>18</volume>(<issue>3</issue>):<fpage>279</fpage>-<lpage>88</lpage>.<pub-id pub-id-type="pmid">19932675</pub-id>
</mixed-citation></ref><ref id="R48"><mixed-citation publication-type="journal"><string-name><surname>Steagall</surname>
<given-names>PVM</given-names></string-name>, <string-name><surname>Mantovani</surname>
<given-names>FB</given-names></string-name>, <string-name><surname>Ferreira</surname>
<given-names>TH</given-names></string-name>, <string-name><surname>Salcedo</surname>
<given-names>ES</given-names></string-name>, <string-name><surname>Moutinho</surname>
<given-names>FQ</given-names></string-name>, <string-name><surname>Luna</surname>
<given-names>SPL</given-names></string-name>. <article-title>Evaluation of the adverse effects of oral firocoxib in healthy dogs</article-title>. <source>J Vet Pharmacol Ther</source>. <year>2007 Jun</year>;<volume>30</volume>(<issue>3</issue>):<fpage>218</fpage>-<lpage>23</lpage>.<pub-id pub-id-type="pmid">17472653</pub-id>
</mixed-citation></ref><ref id="R49"><mixed-citation publication-type="journal"><string-name><surname>Taylor-Brown</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>Meeson</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Brodbelt</surname>
<given-names>DC</given-names></string-name>, <string-name><surname>Church</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>McGreevy</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Thomson</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>O&#x02018;Neill</surname>
<given-names>DG</given-names></string-name>. <article-title>Epidemiology of cranial cruciate ligament disease diagnosis in dogs attending primary-care veterinary practices in England</article-title>. <source>Vet Surg</source>. <year>2015 Aug</year>;<volume>44</volume>(<issue>6</issue>):<fpage>777</fpage>-<lpage>83</lpage>.<pub-id pub-id-type="pmid">26118493</pub-id>
</mixed-citation></ref><ref id="R50"><mixed-citation publication-type="journal"><string-name><surname>Tchetina</surname>
<given-names>EV</given-names></string-name>. <article-title>Developmental mechanisms in articular cartilage degradation in osteoarthritis</article-title>. <source>Arthritis</source>. <year>2011</year>;<volume>2011</volume>: <fpage>683970</fpage>.<pub-id pub-id-type="pmid">22046522</pub-id>
</mixed-citation></ref><ref id="R51"><mixed-citation publication-type="journal"><string-name><surname>Unemori</surname>
<given-names>EN</given-names></string-name>, <string-name><surname>Bair</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Bauer</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Amento</surname>
<given-names>EP</given-names></string-name>. <article-title>Stromelysin expression regulates collagenase activation in human fibroblasts. Dissociable control of two metalloproteinases by interferon-gamma</article-title>. <source>J Biol Chem</source>. <year>1991 Dec 5</year>;<volume>266</volume>(<issue>34</issue>): <fpage>23477</fpage>-<lpage>82</lpage>.<pub-id pub-id-type="pmid">1660474</pub-id>
</mixed-citation></ref><ref id="R52"><mixed-citation publication-type="journal"><string-name><surname>Vander Doelen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Jelley</surname>
<given-names>W</given-names></string-name>. <article-title>Non-surgical treatment of patellar tendinopathy: A systematic review of randomized controlled trials</article-title>. <source>J Sci Med Sport</source>. <year>2020 Feb</year>;<volume>23</volume>(<issue>2</issue>):<fpage>118</fpage>-<lpage>24</lpage>.<pub-id pub-id-type="pmid">31606317</pub-id>
</mixed-citation></ref><ref id="R53"><mixed-citation publication-type="journal"><string-name><surname>Vassalotti</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Musco</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Lombardi</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Calabro</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Tudisco</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mastellone</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Grazioli</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bianchi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Cutrignelli</surname>
<given-names>MI</given-names></string-name>. <article-title>Nutritional management of search and rescue dogs</article-title>. <source>J Nutr Sci</source>. <year>2017 Aug</year>;<volume>6</volume>:<fpage>e44</fpage>.<pub-id pub-id-type="pmid">29152248</pub-id>
</mixed-citation></ref><ref id="R54"><mixed-citation publication-type="journal"><string-name><surname>Vasseur</surname>
<given-names>PB</given-names></string-name>, <string-name><surname>Berry</surname>
<given-names>CR</given-names></string-name>. <article-title>Progression of stifle osteoarthrosis following reconstruction of the cranial cruciate ligament in 21 dogs</article-title>. <source>Am J Vet Res</source>. <year>1992</year>;<volume>28</volume>(<issue>2</issue>):<fpage>129</fpage>-<lpage>36</lpage>.</mixed-citation></ref><ref id="R55"><mixed-citation publication-type="journal"><string-name><surname>Vilar</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Manera</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Santana</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Spinella</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Rodriguez</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Rubio</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Carrillo</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Sopena</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Batista</surname>
<given-names>M</given-names></string-name>. <article-title>Effect of leukocyte-reduced platelet-rich plasma on osteoarthritis caused by cranial cruciate ligament rupture: A canine gait analysis model</article-title>. <source>PLoS One</source>. <year>2018 Mar 19</year>;<volume>13</volume>(<issue>3</issue>):<fpage>e0194752</fpage>.<pub-id pub-id-type="pmid">29554150</pub-id>
</mixed-citation></ref><ref id="R56"><mixed-citation publication-type="journal"><string-name><surname>Xie</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Huangfu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>He</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>J</given-names></string-name>. <article-title>Autologous conditioned plasma enhances autograft revascularization and reinnervation in a dog model of anterior cruciate ligament reconstruction</article-title>. <source>J Surg Res</source>. <year>2013 Jul</year>;<volume>183</volume>(<issue>1</issue>):<fpage>214</fpage>-<lpage>22</lpage>.<pub-id pub-id-type="pmid">23472861</pub-id>
</mixed-citation></ref></ref-list></back></article>